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A New Era i n "
Chemical Information:
PubChem, DiscoveryGate, and Chemistry Central
By Svetla Baykoucheva
Selecting relevant information and suppressing details is the sort
of pragmatic fudging everyone does every day. It's a way of coping
vv/t/i too much information. For almost everything you see, hear, taste,
smell, or touch, you have the choice between examining details
by scrutinizing very closely and looking at the "big picture" with its
other priorities.
-Lisa Randall (2006). Warped Passages: Unraveling
the Mysteries of the Universe's Hidden Dimensions, p. 29
r i U W we go ahout finding the infor-
mation we need, whether it's chemical
or not, depends on how detailed we
want this information to be and how we
want it organized. Researchers and
information specialists are accustomed
to searching bibliographic databases
to find references to articles published
in scientific journals. In some cases,
though, having the information about
a chemical compound summarized in
one place rather than trying to extract
specific data from different papers
saves a lot of time. To use an analogy
from Lisa Randall's book, Warped Pas-
sages: Unraveling the Mysteries of the
Universe's Hidden Dimensions (Harper
Perennial, 2006), we could live with one-
dimensional information (titles and ab-
stracts of papers) or we could add extra
dimensions by using resources that pro-
vide summarized reports of the physi-
cal, chemical, and biological properties
of chemical compounds.
This article will discuss how three
important events that have happened
in the past 2-3 years—the emergence
of PubChem, the introduction of
DiscoveryGate, and the creation of
Chemistry Central—are changing the
field of chemical information.
PUBCHEM
PubChem (http://pubchem.ncbi
.nlm.nih.gov) is a free service that was
launched by the U.S. National Insti-
tutes of Health (NIH) in 2004. It consists
of three databases (PubChem Com-
pound, PubChem Substance, and Pub-
Chem Bio-Assay) linked together and in-
corporated in the Entrez information
retrieval system of the National Center
for Biotechnology Information (NCBl).
PubChem is also an important part of
the NIH's Molecular Libraries Roadmap
Initiative (http://nihroadmap.nih.gov).
PubChem Compound contains more
than 10 million unique structures and
provides biological property informa-
tion for each compound through links
to other Entrez databases.
PubChem Substance contains more
than 17 million records of substances
that were deposited by other organiza-
tions—publishers, suppliers of chemi-
cals, and other vendors. It provides
descriptions of chemicals and links to
PubMed, protein 3-D structures, and
biological screening results. If the
composition of a chemical sample is
known, the description includes links
to PubChem Compound.
While the PubChem Compound
database contains records of chemicals
that have already been identified, the
PubChem Substance database con-
tains records of all chemical substances
that have been submitted to PubChem.
If a component of a sample can be
identified as an individual compound,
it becomes a candidate for inclusion in
the PubChem Compound database.
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PubChem BioAssay can be searched to find information
about bioassays using specific terms pertinent to the bioas-
say. It is also possible to browse or download PubChem Bio-
Assay results. The bioassays' descriptions are also searchable.
You can search PubChem by names of chemicals, ele-
ments, or groups of elements. Other capabilities include
searching by property range, such as temperatures between
one number and another, or drawing a structure and using
the drawing as a query. It is also possible to identify com-
pounds that are similar to those studied.
PubChem has a limited scope of coverage—its goal is to
provide information on small organic molecules. With its 17
million substances and 10 million unique structures, it is
smaller than the CAS Registry File, which has 31 million
organic and inorganic substances and more than 58 million
sequences. You can access the latter through STN, SciFinder,
and SciFinder Scholar, which are subscription-based prod-
ucts from the Chemical Abstracts Service (www.cas.org}, a
branch of the American Chemical Society. The rate, though,
with which PubChem has been growing is really impressive.
Many vendors are now feeding information about chemical
compounds into it. ln 2005, Nature Publishing Group was the
first big commercial publisher to start doing so, followed by
other vendors.
PubChem is a free service. Regardless of whether you are
a librarian, a researcher, a physician, a teacher, a student, or
someone who is simply concerned about a chemical in the
new shampoo that you just bought, PubChem can provide
you with information about the physical, chemical, and bio-
logical properties of many chemicals, including some drugs.
DISCOVERYGATE
DiscoveryGate (DG; www.discoverygate.com) is an online
service from Elsevier MDL that provides access to more than
20 databases through a unified platform called Compound
Index. The databases in DG contain extensive experimental
data derived from journals, patents, chemical catalogs,
major reference works, and Food and Drug Administration
(FDA) documents. They cover more than 27 million struc-
tures, 17 million reactions, and more than 500 million exper-
imentally proven values, which makes DG the largest collec-
tion of chemical properties.
In DG it is possible to search for information on chemical,
physical, and biological properties of chemicals (including
new drugs at different stages of development); to fmd sup-
pliers and compare prices of chemicals; to discover methods
to synthesize new and existing compounds; to associate
structures with experimentally determined property data
retrieved from articles and patents; and to view, in one doc-
ument, data retrieved from different sources. You search DG
via a series of forms, with each form having its own set of
command buttons. DG also allows exporting the results to
reports that can combine data from multiple searches in one
report that can be printed, saved, or exported to an HTML
file. Some of the most important databases in DG are dis-
cussed in what follows. A comprehensive list of the DG data-
bases is avaiiabie at the MDL Web site (www.mdli.com/
solutions/solutions_for/academics/dg_academics.jsp).
CrossFire Beilstein provides access to the buge Beilstein
database, which is the crown jewel of DG. It is the world's most
comprehensive database for compounds, reactions, proper-
ties, and citations. It covers organic chemistry dating from
1771 and contains more than 9.9 million chemical structures
(with 6.5 million of them being unique). It is the world's largest
reaction database, with more than 10 million reactions. Most
of the 320 million chemical properties in it have been exper-
imentally verified. The database also provides access to
900,000 abstracts dating from 1980.
CrossFire Beilstein allows conducting structure search-
ing, reaction searching, and data searching. Until recently,
the Beilstein database was not included in the Compound
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The structure drawing screen in PubChem
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acquired the Beilstein database in March 2007 from the non-
profit Beilstein-Institut (although Elsevier had been involved
with tbe database's production and marketing since 1998), it
is now integrated into the Compound Index of DG.
CrossFire Gmelin is another important database in DG,
with information about inorganic chemicals. It has not yet
been integrated with the Compound Index and must be
searched separately.
MDL Comprehensive Medicinal Chemistry Datahase is
derived from the Drug Compendium in Pergamon's Com-
prehensive Medicinal Cbemistry (CMC). The MDL Compre-
hensive Medicinal Chemistry database provides 3-D models
and important hiochemical properties for more than 8,400
pharmaceutical compounds (1900 to tbe present). It allows
scientists to view more than 7,500 hioactive compounds used
as medicinal agents.
MDL Toxicity Database is a structure-searcbable bio-
activity database of toxic cbemical substances. It contains
data from studies on tbe toxicity, mutagenicity, skin and eye
irritation, tumorigenicity and carcinogenicity, and effects on
reproduction. References to tbe original publications
reporting the toxicity data and to relevant review articles
wben applicable are also included.
MDL Metabolite Database consists of a database, a regis-
trar, and a browser. All data in tbis system is organized into
schemes that depict the transformations and fate of parent
compounds. These could be drugs, agricultural chemicals,
industrial chemicals, or environmental contaminants. Wbile
compiling xenobiotic transformations and metabolic
scbemes from reliable sources, the vendor also allows com-
panies to register and store results of in-bouse metabolism
studies and to share these results with researchers in tbe
same enterprise. It is possible for a researcher to create struc-
ture-searchable metabolic scbemes on a desktop and to
upload tbem to the corporate database. Tbis allows organiza-
tions to get better insigbts Into metabolic activity and the fate
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of candidates for drugs and to coordinate their discovery pro-
grams. Using the browser, scientists can search by structure
to retrieve molecules of interest, as well as structural frag-
ments or specific transformations.
xPharm is a unique resource providing pharmacological
data to researcbers involved in tbe preciinical or discovery
pbase of drug development. A detailed articie (Marie K.
Saimbert, "xPharm: A Preciinical Information Portal for
Discovery Researchers in Institutions of Higher Learning,"
Journal of Electronic Resources in Medical Libraries. 3(1),
2006, p. 63; www.mdl.com/products/pdfs/xpbarm.pdf) pro-
vides information about tbis resource.
The main users of DG are tbe pharmaceutical, chemical,
and biotechnology companies, as well as some academic
institutions thai can afford it. With its ricb content, DG could
be very useful to researchers not only in the chemistry field,
but also to those working in the life sciences.
CHEMISTRY CENTRAL
Chemistry Central (www.chemistrycentral.com) is a new
open access service for cbemistry and related disciplines that
was launched by BioMed Central in 2006. It allows free
access to peer-reviewed articles published in tbe Chemistry
Central Journal and tbe BioMed journals, as well as to arti-
cles published in independent journals that are using the
BioMed publisbing services.
Chemistry Central currently provides access to tbe
Beilstein Journal of Organic Chemistry. BMC Biochemistry.
BMC Chemical Biology, BMC Structural Biology, Carbon
Balance and Management, Chemistry Central Journal, and
Ceochemical Transactions. As with many other open access
ventures, Cbemistry Central tests new husiness models. Brian
Vickery, editorial director of Chemistry Central, discussed
these more fully in a recent interview (Svetla Baykoucbeva,
"Paving the Road to More Open Access for Cbemistry: An
InterviewwitbBrianVickery, Editorial Director of Chemistry,"
DiscoveryGate's main interface
Search screen of CrossFire Beilstein in DG. The structure of beta-amino
pyridine was drawn and used to search for information on ttiis compound
rather than searching by its name.
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Searc/) screen of the MDL Medicinal Chemistry database in DG.
The search is for Lipitor, also known as Atorvastatin,
a widely prescribed cholesterol-lowering drug.
MDL® Metabolite Database
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rfte properties page of the MDL Metabolite Database, showing information
about the metabolism of Lipitor
Chemistry Central's home page
Chemical Information Bulletin.V. 59, No. 1, pp. 13-15; bttp://
acscinf.org/docs/publications/Interviews/Vickery/2007).
NOT JUST FOR CHEMISTS
Althougb I bave often used tbe pbrase "cbemical infor-
mation" tbrougbout tbis article, I would like to empbasize
tbat cbetnistry and the life sciences bave becotne so inter-
twined that tbe resources I discuss here can greatly benefit
researcbers in tbe life sciences too. Very often, though, tbey
are not familiar witb tbese resources and/or are not aware
that their organizations subscribe to tbem. To belp, a
comprebensive list of cbemistry databases bas been posted
(www.cbembiogrid.org/related/resources/about.html).
Researcbers and practitioners in the biomedical field can
find useful information about drugs througb PubChem,
wbicb is now cross-indexed with the Compound Index of DG.
Users of one of tbese two information systems can immedi-
ately see if related information exists in tbe other system.
Only subscribers to DG, tbougb, could get full access to both
systems. PubCbem users get free searching of both systems
and full access to PubCbem results.
ACCEPTANCE FACTORS
Several factors will have an impact on how DG is accepted
by librarians and end users. It is an expensive service tbat
many organizations cannot afford, especially witb ever-
shrinking library budgets. At tbe University of Maryland,
wbicb is not one of tbe wealthiest academic institutions, we
bave a campuswide license for DG tbat allows everyone
affiliated witb the university to use tbis service, even from
home (tbrougb a virtual private network, or VPN). We were
able to switch, for the same price, from tbe Commander plat-
form for CrossFire Beilstein and CrossFire Gmelin to
DiscoveryGate, whicb is a mucb richer resource. I include DG
in all my classes for tbe cbemistry courses I teach, and tbe
students are fascinated by wbat tbey can do with it. I bave
also done several seminars for librarians, showing tbem how
to find relevant and unbiased information about drugs.
Tbe other issue with DG—learning bow to use it—can be
a long and frustrating experience, even for cbemists. Elsevier
MDL provides WebEx and on-site training, as well as excel-
lent instructional materials, but DG is a sophisticated prod-
uct tbat requires a lot of time and dedication on the part of
anyone wanting to use it. Tbe rewards for researcbers, tbougb,
are enormous. Tbere are some librarians and faculty mem-
bers who are still reluctant to embrace DG; tbey continue to
access CrossFire Beilstein and CrossFire Gmelin tbrougb tbe
old Commander interface ratber than through DG.
The collaboration between a free (PubCbem) and a pro-
prietary (DG) service is a new model for providing scientific
information. It is of great benefit to researcbers, as the con-
tent of different information systems can be used togetber,
thus eliminating unnecessary, repetitious searches per-
formed in separate databases.
Not that long ago, you would often hear people saying that
tbe cbemistry field had been lagging behind otber disciplines
in enjoying free access to information. The events discussed
in this article are proving that this cliche is outdated.
Svetla Baykoucheva (sbaykouc@umd.edu) is head of the Wliite
Memorial Chemistry Library of rhe Unirersily of Maryland-Coilege Park
and the editor of the Chemical Information Bulletin, published by the
Chemical Information Division of the American Chemical Society (ACS).
For 8 years, from 1997 until 2005. she was manager af the ACS Library and
Information Center in Washington, D.C.
Comments? Email letters to the editor to marydee@xmission.com.
20 www.onlinemag.net

